These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report]. Macioszek A, Baczyk M, Kopeć T, Sowiński J. Endokrynol Pol; 2008 May; 59(5):403-10. PubMed ID: 18979451 [Abstract] [Full Text] [Related]
12. [Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy (author's transl)]. Albrecht HH, Creutzig H. Rofo; 1976 Dec; 125(6):546-51. PubMed ID: 137852 [Abstract] [Full Text] [Related]
13. Sialadenitis following radioiodine therapy - a new diagnostic and treatment modality. Nahlieli O, Nazarian Y. Oral Dis; 2006 Sep; 12(5):476-9. PubMed ID: 16910918 [Abstract] [Full Text] [Related]
17. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer. Bohuslavizki KH, Klutmann S, Brenner W, Kröger S, Buchert R, Bleckmann C, Mester J, Henze E, Clausen M. Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133 [Abstract] [Full Text] [Related]